Gary P Wiesehahn

Title: Innovations and Contributions of Gary P. Wiesehahn

Introduction

Gary P. Wiesehahn is a notable inventor based in Alameda, California, with a significant portfolio of eight patents. His work primarily focuses on advancements in biological compositions and viral inactivation methods, contributing to the fields of medicine and biotechnology.

Latest Patents

Among his latest patents is a method of blood component decontamination by glucose addition. This innovative approach involves treating biological compositions with psoralen derivatives under specific irradiation conditions, ensuring that proteins retain their physiological activities while rendering any present polynucleotides inactive. Additionally, he has developed a preparation method for inactivated viral vaccines. This method employs psoralen-inactivation of live viruses in a non-oxidizing atmosphere, which helps preserve the antigenic characteristics of the viruses, thereby enhancing the efficacy of vaccines designed to inhibit viral infections.

Career Highlights

Throughout his career, Gary has worked with several prominent organizations, including Diamond Scientific Company and Advanced Genetics Research Institute. His contributions to these companies have been instrumental in advancing research and development in the field of biological sciences.

Collaborations

Gary has collaborated with notable professionals in his field, including David R. Stevens and Richard E. Giles. These collaborations have further enriched his work and expanded the impact of his innovations.

Conclusion

Gary P. Wiesehahn's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His innovative methods for blood decontamination and vaccine preparation continue to influence medical practices and research.